可植入式接触镜治疗近视的研究进展

Advancement in implantable contact lenses for myopia

有晶状体眼人工晶状体植入术是一种可逆性屈光手术,它保留了患者自身晶状体的调节功能。相比激光和其他切削眼角膜组织的手术,它产生更小的高阶像差。尽管如此,作为眼内的一种手术,它也有一些潜在的风险,如白内障、角膜内皮细胞的丢失、慢性葡萄膜炎、色素分散性青光眼、瞳孔阻滞性青光眼、散光等。目前,只有两种后房型人工晶状体运用于临床,可植入式接触镜和有晶状体眼屈光镜。相比而言,临床运用更多的是可植入式接触镜。本文将会对ICL的发展历史、当前模型、选择标准以及在中、高度近视的临床应用和术后并发症进行综述。

Implantation of phakic intraocular lenses（ pIOLs） is a reversible refractive procedure,preserving the patient＇s accommodative function with minimal induction of higher order aberrations compared with corneal photoablative procedures. Despite this,as an intraocular procedure,it has potential risks such as cataracts,corneal endothelial cell loss,chronic uveitis,pigmentary dispersion glaucoma,papillary block glaucoma,astigmatism,or endophthalmitis. Currently,only two models of posterior chamber pIOLs are commercially available,the implantable collammer lens（ STAAR Surgical Co.） and the phakic refractive lens（ PRL; Zeiss Meditec）. compared to PRL,there are more implantable contact lens used in clinical. The present article reviews the history,current models,selection criteria,clinical outcomes and complications for moderate to high myopia treated with implantable contact lenses.